Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Dexibuprofen is a pharmacologically active enantiomer of racemic ibuprofen (NSAID) used to treat pain and inflammation. It is a pharmacologically effective enantiomer of racemic ibuprofen that differs in physicochemical properties.
- Mechanism
- Curator reviewed · 1 reference
Like common NSAIDs, dexibuprofen is an active enantiomer of ibuprofen that suppresses the prostanoid synthesis in the inflammatory cells via inhibition of the COX-2 isoform of the arachidonic acid COX. For more information, refer to ibuprofen.
- Primary indication
- For more information, refer to ibuprofen.Curator reviewed · 6 structured indications
- Formula / weight
- C13H18O2 · 206.2808 g/mol (avg)
- Also known as
- d-ibuproten
Resolves to
HEFNNWSXXWATRW-JTQLQIEISA-NSMILESCC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=OWhat you can answer from here — as of June 15, 2026
Which drugs share a target with Dexibuprofen, and which of those have an active Phase 3 trial?